Craniomaxillofacial Fixation Devices Market to Grow with a CAGR of 8.34% through 2028

Increasing demand for innovative, minimally invasive, and aesthetic craniofacial procedures is expected to drive the Global Craniomaxillofacial Fixation Devices Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Craniomaxillofacial Fixation Devices Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Craniomaxillofacial Fixation Devices Market stood at USD 1.51 billion in 2022 and is anticipated to grow with a CAGR of 8.34% in the forecast period, 2024-2028. This can be attributed to the regulatory environment. Stringent regulatory standards in developed markets like North America and Europe are pushing manufacturers to develop high-quality, safe, and effective craniofacial fixation devices. This has created a competitive landscape where companies invest heavily in research and development to meet regulatory requirements while maintaining their market positions.

In addition, to streamline the introduction of new devices to global markets, there is a growing effort towards regulatory harmonization. Aligning regulatory standards between countries and regions reduces the time and resources required for product approvals. This trend benefits both manufacturers and patients by accelerating access to innovative devices.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Craniomaxillofacial Fixation Devices Market.”

The advent of the COVID-19 pandemic led to a halt in many elective medical procedures, as healthcare facilities were overwhelmed by COVID-19 cases. According to the American Society of Plastic Surgeons, this hiatus also impacted reconstructive surgical procedures, including Maxillofacial Surgery, which experienced a decline.

In addition to this, the increase in facial and head injuries resulting from sports-related accidents is expected to drive the demand for craniomaxillofacial devices. The Centers for Disease Control and Prevention (CDC) reported an estimated 1.7 to 3.8 million traumatic brain injuries occurring annually in the U.S., with 10.0% attributed to sports and recreational activities.

Furthermore, data from the U.S. Consumer Product Safety Commission (CPSC) revealed that in 2018 alone, 454,407 sports-related head injuries were treated in U.S. hospital emergency rooms. This underscores the significant growth potential for craniomaxillofacial device manufacturers in the country.

The rising incidence of road accidents is also expected to drive the demand for craniomaxillofacial devices. According to the Department of Neurology at Columbia University, motor vehicle accidents are a leading cause of Traumatic Brain Injury (TBI) among both children and adults in the U.S. This trend is mirrored globally, especially in developing countries, where an increase in road accidents is anticipated to boost demand for craniomaxillofacial devices.

In 2020, the American Society of Plastic Surgeons reported that approximately 256,085 maxillofacial reconstructive surgery procedures were performed in the U.S. Maxillofacial reconstructive surgery is among the top five most commonly performed plastic surgery procedures in the country. Furthermore, John Hopkins Medicine reported that over 3.5 million sports-related injuries are reported annually in the U.S., with sports-related injuries accounting for nearly one-third of all childhood injuries.

The COVID-19 pandemic had a significant impact on the craniomaxillofacial devices market. It resulted in the cancellation and rescheduling of surgical procedures on a global scale. For craniomaxillofacial (CMF) surgeons, the focus shifted to urgent or emergent cases, leading to a decline in products offered by key manufacturers like Medartis AG. This decline was due to the suspension of elective procedures, leading to production stoppages and supply chain disruptions.

Similarly, Reni Shaw Plc., a major player in CMF implants in Europe, reported in its annual report that its medical dental line experienced decreased sales in 2020 due to reduced demand for additively manufactured CMF implants and dental structures caused by the pandemic and the decrease in non-essential surgeries.

However, the market showed signs of recovery in 2021, as many competitors experienced growth in the sales of CMF products when medical surgeries resumed under strict COVID-19 safety protocols.

The Global Craniomaxillofacial Fixation Devices Market is segmented into product, material, application, end-user, regional distribution, and company.

Based on its material, metallic implants emerged as the dominant material category in the market in 2022. This can be attributed to several factors, including their reduced susceptibility to corrosion, their capacity to provide robust support for fractures, their relatively lower cost compared to bioabsorbable alternatives, and their wider market presence compared to other materials. The use of metals in CMF surgery is favored because of their lower corrosive properties and their ability to provide physiological support for fractures. Among these metals, titanium and its alloys are the most commonly employed materials for CMF surgery. This preference is due to several advantages associated with them, such as their lightweight nature, inert metallic characteristics, the strength they impart to implants, their high acceptance by bodily tissues, and their resistance to corrosion. Titanium and its alloys are frequently utilized in procedures such as mandibular reconstruction.

Bioabsorbable materials are anticipated to experience the most rapid growth during the forecast period. The adoption of these implants eliminates the need for a second surgery, which is often necessary with metallic implants, and they are easily integrated into the body's system. Technological advancements in CMF surgery, such as self-enforced technology, have led to the development of biocompatible materials that are easily manageable, possess degradable properties, and offer reliability. These factors are expected to drive market growth.

Based on application, orthognathic and dental surgery achieved the highest revenue share in 2022. In terms of applications, the market is divided into neurosurgery & ENT, orthognathic & dental surgery, and plastic surgery. The dominance in revenue was primarily attributed to the extensive utilization of orthognathic and dental surgery in addressing a wide range of both minor and major skeletal and dental deformities.

On the other hand, the neurosurgery & ENT segment exhibited the most rapid growth. This growth can be attributed to the rising incidence of trauma and spinal disorders that necessitate Cerebrospinal Fluid (CSF) management during surgical procedures. Surgeons often perform craniotomies to gain improved access to the brain during neurosurgery. Craniotomies are employed in the treatment of various conditions, including trauma, brain infections, skull fractures, aneurysms, epilepsy, Parkinson's disease, intracranial pressure following a stroke or injury, and the removal of blood clots resulting from head injuries.

Major companies operating in Global Craniomaxillofacial Fixation Devices Market are:

• DePuy Synthes Inc
• Stryker Corp
• Medtronic PLC
• Zimmer Biomet Holdings, Inc.
• B Braun Melsungen AG
• Renishaw plc
• Medartis AG
• KLS-Martin LP
• Synemed Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The future of the Global Craniomaxillofacial Fixation Devices Market is filled with exciting trends and innovations. Patient-specific implants, biodegradable devices, smart technology integration, minimally invasive approaches, VR/AR surgical planning, telemedicine, global expansion, and regulatory harmonization are key trends that will shape the industry. As the trends unfold, patients can expect safer, more effective, and more accessible craniofacial care, while surgeons and manufacturers continue to push the boundaries of medical technology and innovation,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Craniomaxillofacial Fixation Devices Market By Product (Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint Replacement, Thoracic Fixation, Bone Graft Substitute, CMF Plate and Screw Fixation), By Material (Metal, Bio Absorbable Material, Ceramic), By Application (Neurosurgery & ENT, Orthognathic and Dental Surgery, Plastic Surgery, Others), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Craniomaxillofacial Fixation Devices Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Craniomaxillofacial Fixation Devices Market.

Contact

Techsci Research LLC

420 Lexington Avenue,  Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Web: https://www.techsciresearch.com/